Regular use can lead to a more youthful, radiant, and healthy-looking skin
[11] PubChem NNMTi (5-Amino-1-methylquinolinium iodide compound listing).
Uncommon and rare adverse effects include cystitis, folliculitis, gastrointestinal infections, hypersensitivity reactions, changes in appetite, depression, insomnia, balance disorders, lethargy, restless leg syndrome, syncope, photophobia, presbyopia, tinnitus, confusion, palpitations, hypertension, hypercholesterolaemia, and weight gain
Its role in research is exploratory and focused on mechanistic understanding, rather than producing therapeutic outcomes
It's not always the case but it does come to mind
It is the first drug to pair a GLP-1 receptor agonist with an amylin analogue for weight loss